Dr. Sheldon L. Holder, MD, PhD
Claim this profilePenn State Cancer Institute
Studies Cancer
Studies Renal Cell Carcinoma
1 reported clinical trial
2 drugs studied
More about Sheldon L. Holder, MD, PhD
Clinical Trial Related5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Sheldon L. Holder, MD, PhD has experience with
- Abemaciclib
- Sunitinib
Breakdown of trials Sheldon L. Holder, MD, PhD has run
Renal Cell Carcinoma
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sheldon L. Holder, MD, PhD specialize in?
Sheldon L. Holder, MD, PhD focuses on Cancer and Renal Cell Carcinoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Sheldon L. Holder, MD, PhD currently recruiting for clinical trials?
No, Sheldon L. Holder, MD, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Sheldon L. Holder, MD, PhD has studied deeply?
Yes, Sheldon L. Holder, MD, PhD has studied treatments such as Abemaciclib, Sunitinib.
What is the best way to schedule an appointment with Sheldon L. Holder, MD, PhD?
Apply for one of the trials that Sheldon L. Holder, MD, PhD is conducting.
What is the office address of Sheldon L. Holder, MD, PhD?
The office of Sheldon L. Holder, MD, PhD is located at: Penn State Cancer Institute, Hershey, Pennsylvania 17033 United States. This is the address for their practice at the Penn State Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.